IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year

Go back to IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
(NASDAQ: ICCM) Delayed: 1.96 -0.03 (1.51%)
Previous Close $1.99    52 Week High
Open $2.06    52 Week Low
Day High $2.06    P/E N/A 
Day Low $1.95    EPS
Volume 80,260